Articles tagged with Kinase Domains
Researchers characterized a hidden intermediate state in Src kinase function, which enables rapid phosphorylation and is essential for T-cell activation and cell migration. This study expands our understanding of kinase function and sets the stage for new therapeutic approaches that selectively target these conformational states.
Researchers uncover a novel immune mechanism by which wheat tandem kinase proteins (TKPs) combat pathogen invasion, establishing a new paradigm for cooperation between TKPs and NLR proteins. The discovery offers a foundation for engineering crop varieties with broad-spectrum pathogen resistance.
Researchers found that necroptosis promotes metastasis in breast cancer models, and blocking it leads to inhibition of metastasis. Necroptosis may be a key factor in tumor progression, and targeting its regulators could be critical for mitigating metastasis.
Researchers at UMass Amherst have identified a new regulatory role for CaMKII, a protein involved in calcium signaling, in the brain's memory center. They found that the hub domain of CaMKII plays a crucial role in tuning its sensitivity to calcium, opening up new avenues for investigation and potential therapeutic targets.
A team of scientists has identified a network of interaction partners for the juxtamembrane segment of the EGF receptor, which can influence cell growth and development. This breakthrough may lead to new therapeutic approaches for cancers that have become resistant to current active ingredients.
Researchers have created a 3D map of the doublecortin kinase like domain 1 (DCLK1) protein, which is linked to various types of cancers. The study provides new information on how DCLK1 functions and contributes to cancer formation.
Research on LRRK2 protein mutation G2019S reveals potential drawbacks of blocking its kinase activity. In a study published in Molecular Neurodegeneration, deleting the kinase domain of LRRK2 led to changes in motor coordination and anxiety-like behaviors in mice without affecting dopamine signaling.
Scientists have determined the three-dimensional structure of Death Associated Protein Kinase (DAPK) and created a quantitative assay to measure its activity. This breakthrough may lead to new drugs that can reduce cell damage following brain injuries and strokes.